Anumana’s AI ECG Technology Recognized in CMS 2025 Rule, Expanding Cardiovascular Care
Anumana, a leading AI-driven health technology company, announced that the Centers for Medicare & Medicaid Services (CMS) has recognized its low ejection fraction (LEF) ECG-AI™ technology in the 2025 Hospital…
Genmab to Highlight Epcoritamab-bysp Development at 2024 ASH Annual Meeting
Genmab A/S (Nasdaq: GMAB) today announced that over 20 abstracts evaluating epcoritamab-bysp (EPKINLY®), a subcutaneously administered T-cell engaging bispecific antibody, will be presented at the 66th Annual Meeting of the…
Shelley Gandhi Joins ELIQUENT to Lead Expanded Pharmacovigilance Services
ELIQUENT Life Sciences, a global regulatory consulting firm, is pleased to announce the addition of Shelley Gandhi, a renowned pharmacovigilance (PV) expert, to its team. This strategic hire strengthens ELIQUENT’s…
Immunis Launches Preclinical Studies for Canine Muscle Atrophy Treatment
Immunis, Inc., a clinical-stage biotechnology company focused on developing innovative secretomes for age-related diseases and immune dysfunction, has launched non-terminal safety studies for canine muscle atrophy in collaboration with VetBio…
LumiThera Receives FDA Approval for Valeda Treatment for Dry AMD
LumiThera Inc., a medical device company specializing in photobiomodulation (PBM) therapy for ocular conditions, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for its…
GeneDx to Present Key Research at ASHG Annual Meeting
GeneDx (Nasdaq: WGS), a leader in leveraging genomic insights to improve health outcomes, today announced its scientific contributions for the 2024 American Society of Human Genetics (ASHG) Annual Meeting. GeneDx…
Inquis Medical Secures $40M in Series B Funding to Advance Aventus Thrombectomy System
Inquis Medical, an innovator in advanced thrombectomy systems, today announced the successful closure of its oversubscribed $40 million Series B financing round. The round was led by Marshall Wace, a…
Tempus Reports Q3 2024 Results, Agrees to Acquire Ambry Genetics
Tempus AI, Inc. (NASDAQ: TEM), a technology company at the forefront of using AI to advance precision medicine and patient care, today reported its financial results for the third quarter…
BlueWind Medical Announces CMS Approval for 2025 Reimbursement of Revi® System
BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and developer of the Revi® System for treating urge urinary incontinence (UUI), announced that the Centers for Medicare & Medicaid…
Universal Health Services Named Top Employer by American Opportunity Index
Universal Health Services (NYSE: UHS) has been named one of the Top 100 Employers of Choice in the 2024 American Opportunity Index, which evaluates how effectively companies develop talent and…
Ria Health Appoints Dr. Martin Rosenzweig to Board of Directors
Ria Health, a national leader in telehealth treatment for Alcohol Use Disorder (AUD), has announced the appointment of Dr. Martin Rosenzweig to its Board of Directors. With over 25 years…
Cardinal Health Reports Q1 FY 2025 Results, Raises Outlook
Cardinal Health (NYSE: CAH) reported its first-quarter fiscal year 2025 revenue at $52.3 billion, a 4% decline compared to the same quarter in fiscal year 2024. Excluding the impact of…